Transferrin receptor expression by non-Hodgkin's lymphoma. Correlation with morphologic grade and survival

L. J. Medeiros, Louis Picker, S. J. Horning, R. A. Warnke

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The monoclonal antibody OKT9 was applied to cryostat sections of 267 non-Hodgkin's lymphomas and related neoplasms. It was found that the transferrin receptor is expressed by a wide variety of B- and T-lineage non-Hodgkin's lymphomas. The OKT9 staining also was loosely correlated with the three morphologic grades of non-Hodgkin's lymphomas identified by the International Working Formulation. In general, higher grade lymphomas more often and more intensely expressed the T9 antigen. However, transferrin receptor expression by certain histologic subtypes of lymphoma did not correlate with their morphologic grade: low-grade follicular lymphomas expressed the T9 antigen more frequently than diffuse low-grade lymphomas; diffuse small cleaved cell lymphomas were stained by OKT9 less often than other histologic subtypes of intermediate-grade lymphomas; and diffuse immunoblastic lymphomas expressed transferrin receptors less often than the other high-grade histologic subtypes of non-Hodgkin's lymphoma. Intermediate lymphocytic lymphomas, not recognized in the International Working Formulation, were infrequently and weakly stained by OKT9 in a manner similar to diffuse low-grade lymphomas. We obtained clinical follow-up data on 43 individuals with chronic lymphocytic leukemia/small lymphocytic lymphoma and 64 individuals with diffuse large cell and immunoblastic lymphoma. Transferrin receptor expression in these two groups did not correlate significantly with survival.

Original languageEnglish (US)
Pages (from-to)1844-1851
Number of pages8
JournalCancer
Volume61
Issue number9
StatePublished - 1988
Externally publishedYes

Fingerprint

Transferrin Receptors
Non-Hodgkin's Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Large-Cell Immunoblastic Lymphoma
Mantle-Cell Lymphoma
Antigens
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Transferrin receptor expression by non-Hodgkin's lymphoma. Correlation with morphologic grade and survival. / Medeiros, L. J.; Picker, Louis; Horning, S. J.; Warnke, R. A.

In: Cancer, Vol. 61, No. 9, 1988, p. 1844-1851.

Research output: Contribution to journalArticle

Medeiros, L. J. ; Picker, Louis ; Horning, S. J. ; Warnke, R. A. / Transferrin receptor expression by non-Hodgkin's lymphoma. Correlation with morphologic grade and survival. In: Cancer. 1988 ; Vol. 61, No. 9. pp. 1844-1851.
@article{0af91e78dc514df0a0ca1d4c5f2c105d,
title = "Transferrin receptor expression by non-Hodgkin's lymphoma. Correlation with morphologic grade and survival",
abstract = "The monoclonal antibody OKT9 was applied to cryostat sections of 267 non-Hodgkin's lymphomas and related neoplasms. It was found that the transferrin receptor is expressed by a wide variety of B- and T-lineage non-Hodgkin's lymphomas. The OKT9 staining also was loosely correlated with the three morphologic grades of non-Hodgkin's lymphomas identified by the International Working Formulation. In general, higher grade lymphomas more often and more intensely expressed the T9 antigen. However, transferrin receptor expression by certain histologic subtypes of lymphoma did not correlate with their morphologic grade: low-grade follicular lymphomas expressed the T9 antigen more frequently than diffuse low-grade lymphomas; diffuse small cleaved cell lymphomas were stained by OKT9 less often than other histologic subtypes of intermediate-grade lymphomas; and diffuse immunoblastic lymphomas expressed transferrin receptors less often than the other high-grade histologic subtypes of non-Hodgkin's lymphoma. Intermediate lymphocytic lymphomas, not recognized in the International Working Formulation, were infrequently and weakly stained by OKT9 in a manner similar to diffuse low-grade lymphomas. We obtained clinical follow-up data on 43 individuals with chronic lymphocytic leukemia/small lymphocytic lymphoma and 64 individuals with diffuse large cell and immunoblastic lymphoma. Transferrin receptor expression in these two groups did not correlate significantly with survival.",
author = "Medeiros, {L. J.} and Louis Picker and Horning, {S. J.} and Warnke, {R. A.}",
year = "1988",
language = "English (US)",
volume = "61",
pages = "1844--1851",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Transferrin receptor expression by non-Hodgkin's lymphoma. Correlation with morphologic grade and survival

AU - Medeiros, L. J.

AU - Picker, Louis

AU - Horning, S. J.

AU - Warnke, R. A.

PY - 1988

Y1 - 1988

N2 - The monoclonal antibody OKT9 was applied to cryostat sections of 267 non-Hodgkin's lymphomas and related neoplasms. It was found that the transferrin receptor is expressed by a wide variety of B- and T-lineage non-Hodgkin's lymphomas. The OKT9 staining also was loosely correlated with the three morphologic grades of non-Hodgkin's lymphomas identified by the International Working Formulation. In general, higher grade lymphomas more often and more intensely expressed the T9 antigen. However, transferrin receptor expression by certain histologic subtypes of lymphoma did not correlate with their morphologic grade: low-grade follicular lymphomas expressed the T9 antigen more frequently than diffuse low-grade lymphomas; diffuse small cleaved cell lymphomas were stained by OKT9 less often than other histologic subtypes of intermediate-grade lymphomas; and diffuse immunoblastic lymphomas expressed transferrin receptors less often than the other high-grade histologic subtypes of non-Hodgkin's lymphoma. Intermediate lymphocytic lymphomas, not recognized in the International Working Formulation, were infrequently and weakly stained by OKT9 in a manner similar to diffuse low-grade lymphomas. We obtained clinical follow-up data on 43 individuals with chronic lymphocytic leukemia/small lymphocytic lymphoma and 64 individuals with diffuse large cell and immunoblastic lymphoma. Transferrin receptor expression in these two groups did not correlate significantly with survival.

AB - The monoclonal antibody OKT9 was applied to cryostat sections of 267 non-Hodgkin's lymphomas and related neoplasms. It was found that the transferrin receptor is expressed by a wide variety of B- and T-lineage non-Hodgkin's lymphomas. The OKT9 staining also was loosely correlated with the three morphologic grades of non-Hodgkin's lymphomas identified by the International Working Formulation. In general, higher grade lymphomas more often and more intensely expressed the T9 antigen. However, transferrin receptor expression by certain histologic subtypes of lymphoma did not correlate with their morphologic grade: low-grade follicular lymphomas expressed the T9 antigen more frequently than diffuse low-grade lymphomas; diffuse small cleaved cell lymphomas were stained by OKT9 less often than other histologic subtypes of intermediate-grade lymphomas; and diffuse immunoblastic lymphomas expressed transferrin receptors less often than the other high-grade histologic subtypes of non-Hodgkin's lymphoma. Intermediate lymphocytic lymphomas, not recognized in the International Working Formulation, were infrequently and weakly stained by OKT9 in a manner similar to diffuse low-grade lymphomas. We obtained clinical follow-up data on 43 individuals with chronic lymphocytic leukemia/small lymphocytic lymphoma and 64 individuals with diffuse large cell and immunoblastic lymphoma. Transferrin receptor expression in these two groups did not correlate significantly with survival.

UR - http://www.scopus.com/inward/record.url?scp=0023876611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023876611&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 1844

EP - 1851

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -